
|Articles|October 14, 2009
Emerging Leaderhip Pharma Awards- Frank Karbe
Advertisement
Frank Karbe,
Chief Financial Officer,
Exelixis
Download Adobe Flash Player
Frank Karbe, executive vice president and chief financial officer of Exelixis, reflects on some of the financial, regulatory, and intellectual property challenges facing the biopharma industry and shares his thoughts on what emerging leaders will need to do to address them.Listen to the Podcast for more coverage.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
3
ACS Calls Obesity a Condition That Must Be Treated with Medication and Surgery
4
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
5





